CCMB
- Hyderabad
Hyderabad: CCMB to be open for public, students on September 26
Hyderabad: The ‘Open Day’ event of the Centre for Cellular and Molecular Biology (CCMB), which provides school students with an opportunity to interact with geneticists at the premier genetic institute will be…
- Hyderabad
Hyderabad: CCMB invites applications for Jan 2024 PhD program
Hyderabad: The Hyderabad-based premier genetic research institute Centre for Cellular and Molecular Biology (CCMB) has invited applications for research programs in modern biology. The program is part of its January 2024 PhD…
- Hyderabad
India develops herd immunity; BF.7 variant may not be as serious as in China: CCMB chief
Hyderabad: The severity of BF.7 variant of coronavirus in India may not be as serious as it is currently prevailing in China as Indian have already developed “herd immunity” a top official…
- Hyderabad
Hyderabad: UoH, CCMB’s COVID-19 antidote completes Phase 2 clinical trials
Hyderabad: The University of Hyderabad (UoH) and the Centre for Cellular and Molecular Biology (CCMB) in collaboration with VINCOV-19, developed the first antidote against COVID-19 and have successfully completed the Phase 2…
- Hyderabad
Hyderabad: CCMB scientist selected as member of European Molecular Biology Organisation
Hyderabad: Dr Rajan Sankaranarayanan, a scientist at CSIR-Centre for Cellular and Molecular Biology has been announced as one of the elected Associate Members of the European Molecular Biology Organization (EMBO). This year,…
- Hyderabad
CCMB study unravels basis for side effects of statins
Hyderabad: A study at CSIR-Centre for Cellular & Molecular Biology (CCMB) has unravelled the basis for side effects of statins. Statins are one of the top selling drugs worldwide and are used…
- Hyderabad
Omicron: NCBS monitoring situation in Hyderabad, 3 other cities
Hyderabad: The National Centre for Biological Sciences (NCBS), which confirmed the first two cases of the Omicron variant in Bengaluru on Thursday, is continuously monitoring the situation in four cities – Bengaluru, Hyderabad,…
- Hyderabad
VP Naidu calls for fast-tracking of genome sequencing of new COVID-19 variants
Hyderabad: Vice President Venkaiah Naidu on Friday called for fast-tracking of genome sequencing of new COVID-19 variants to speed up finding suitable vaccines and drugs. Naidu visited CCMB’s LaCONES (Laboratory for the…
- Hyderabad
CCMB lab releases guidelines for COVID testing in zoo animals
Hyderabad: With COVID-19 cases reported in zoo animals in India last month, the Laboratory for the Conservation of Endangered Species (LaCONES) of the CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad, has…
- Hyderabad
Delta variant of COVID-19 predominant in Varanasi: Study
Hyderabad: The Delta variant of COVID-19 is predominant among the variants found in Varanasi and adjoining areas, reveals a joint study by Banaras Hindu University (BHU), Varanasi and CSIR — Centre for…
- Hyderabad
Hyderabad: Dr Vinay Nandicoori appointed as director of CCMB
Hyderabad: Dr Vinay K Nandicoori, a well-known molecular biologist and scientist at DBT- National Institute of Immunology, New Delhi, has now been appointed as the director of the Centre for Cellular and…
- India
CCMB comes up with new COVID-19 testing method using dry swab
Hyderabad: Rakesh Mishra, Director of Center for Cellular and Molecular Biology (CCMB), on Friday said that they have come up with a new way of collecting COVID-19 samples using a dry swab…
- Hyderabad
Hyderabad-based VINS Bioproducts gets DCGI nod to start clinical trials for VINCOV-19
Hyderabad: VINS Bioproducts on Monday received approval from the Drugs Controller General of India (DCGI) to commence the clinical trials for VINCOV-19, an antidote, and a cure against COVID-19, the Hyderabad based…
- India
N440K coronavirus variant spreading more in southern states: CCMB study
Hyderabad: A few novel variants of coronavirus are spreading more in some states in the country and a closer surveillance is needed, a study by the scientists of CSIR-Centre for Cellular and Molecular…
- India
COVID-19: Ayurveda formulations to be tested by CCMB for checking anti-viral efficacy
Hyderabad: Ayurveda formulations would be tested on lab-grown strains of coronavirus by the CSIR-Centre for Cellular and Molecular Biology (CCMB) here to ascertain their anti-viral efficacy in the fight against the pathogen, under…
- 1
- 2